SCHEMBL16166116

SCHEMBL16166116

O=C1C[C@]2(C(=O)Nc3ccc(Cl)cc32)c2cnn(Cc3ccc(Cl)cc3F)c2N1

nearest known ligand 0.49

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 4/20 0.38
AKR1B10 O60218 1/20 0.38
AKR1A1 P14550 1/20 0.38
PDE5A O76074 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16166339 0.90 IP6K1 (0.42) AKR1B1
SCHEMBL16166482 0.90 IP6K1 (0.42) AKR1B1
SCHEMBL16166401 0.87 AKR1B1 (0.40) AKR1B1
SCHEMBL16166247 0.87 AKR1B1 (0.40) AKR1B1
SCHEMBL16166349 0.83 AKR1B1 (0.40) AKR1B1
SCHEMBL16175845 0.83 AKR1B1 (0.40) AKR1B1
SCHEMBL16166268 0.83 ADAMTS5 (0.37) AKR1B1
SCHEMBL16166745 0.83 ELOVL6 (0.37) AKR1B1
SCHEMBL16166530 0.82 AKR1B1 (0.36) AKR1B1
SCHEMBL16175826 0.81 NPBWR1 (0.44) AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014167528-A1 SPIROPYRAZOLOPYRIDINE DERIVATIVES AND USES THEREOF FOR THE TREATMENT OF VIRAL INFECTIONS NOVARTIS AG (CH) 2014-10-16 WO disclosed
WO-2014167528-A1 SPIROPYRAZOLOPYRIDINE DERIVATIVES AND USES THEREOF FOR THE TREATMENT OF VIRAL INFECTIONS NOVARTIS AG (CH) 2014-10-16 WO disclosed